menu
    • menu

    Company profile for IBSA Institut Biochimique

    NEW Drugs in Dev: 18
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a multinational pharmaceutical company with a specific vision of care that we project from our headquarters in Switzerland to the rest of the world, through a process of on-going expansion in Europe, Asia and North America. 14 million vials of hormones, 300 million soft capsules, 60 million packs of finished products: this is the productive capacity on which IBSA is building its history. Established in Lugano in 1945, ...
    We are a multinational pharmaceutical company with a specific vision of care that we project from our headquarters in Switzerland to the rest of the world, through a process of on-going expansion in Europe, Asia and North America. 14 million vials of hormones, 300 million soft capsules, 60 million packs of finished products: this is the productive capacity on which IBSA is building its history. Established in Lugano in 1945, IBSA started developing its special identity in 1985 when it was acquired by the current ownership, which completely overhauled both its vision and its strategy by focusing on the acquisition

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IBSA Institut BiochimiqueSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Via del Piano, 29 CH 6915 Pambio-Noranco, Lugano
    Telephone
    Telephone
    +41 58 360 10 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ibsagroup.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ibsa-sa/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Acertis Pharma Licenses Commercial Rights to Licart from IBSA
    Acertis Pharma Licenses Commercial Rights to Licart from IBSA

    21 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260107363870/en/Acertis-Pharmaceuticals-Licenses-U.S.-Commercial-Rights-to-Licart-from-IBSA

    BUSINESSWIRE
    21 Jan 2026
    Share Share
    Acertis Pharma Licenses Commercial Rights to Licart from IBSA
    Acertis Pharma Licenses Commercial Rights to Licart from IBSA

    07 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260107363870/en/Acertis-Pharmaceuticals-Licenses-U.S.-Commercial-Rights-to-Licart-from-IBSA

    BUSINESSWIRE
    07 Jan 2026
    Share Share
    Ibsa Inst Bio’s Vybrique Receives Approval in US
    Ibsa Inst Bio’s Vybrique Receives Approval in US

    16 Dec 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210858

    FDA
    16 Dec 2025
    Share Share
    IBSA Derma Highlights NAHYCO At IMCAS Asia 2025 Event
    IBSA Derma Highlights NAHYCO At IMCAS Asia 2025 Event

    06 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250603094257/en/IBSA-Derma-at-IMCAS-Asia-2025-spotlight-on-the-future-of-aesthetic-medicine-in-the-10th-Anniversary-Year-of-NAHYCO-Technology

    BUSINESSWIRE
    06 Jun 2025
    Share Share
    IBSA celebrates 40 years of history with
    IBSA celebrates 40 years of history with "Drugs in the best form

    03 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250327550789/en/IBSA-celebrates-40-years-of-history-Drugs-in-the-best-form-a-success-story-that-combines-innovation-with-a-focus-on-people

    BUSINESSWIRE
    03 Apr 2025
    Share Share
    IBSA USA Expands IBSA Care Line With Irosolv™ Supplements
    IBSA USA Expands IBSA Care Line With Irosolv™ Supplements

    04 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250303329642/en

    BUSINESSWIRE
    04 Mar 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search